WO2002013845A3 - Inflammation associee au recepteur couple a la proteine g - Google Patents
Inflammation associee au recepteur couple a la proteine g Download PDFInfo
- Publication number
- WO2002013845A3 WO2002013845A3 PCT/EP2001/009466 EP0109466W WO0213845A3 WO 2002013845 A3 WO2002013845 A3 WO 2002013845A3 EP 0109466 W EP0109466 W EP 0109466W WO 0213845 A3 WO0213845 A3 WO 0213845A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- coupled receptor
- protein coupled
- inflammation related
- polynucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002212140A AU2002212140A1 (en) | 2000-08-18 | 2001-08-16 | Inflammation related g-protein coupled receptor |
EP01980246A EP1364017A2 (fr) | 2000-08-18 | 2001-08-16 | Inflammation associee au recepteur couple a la proteine g |
JP2002518985A JP2004505648A (ja) | 2000-08-18 | 2001-08-16 | 炎症関連gタンパク質共役受容体 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64165300A | 2000-08-18 | 2000-08-18 | |
US09/641,653 | 2000-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002013845A2 WO2002013845A2 (fr) | 2002-02-21 |
WO2002013845A3 true WO2002013845A3 (fr) | 2003-07-10 |
Family
ID=24573290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/009466 WO2002013845A2 (fr) | 2000-08-18 | 2001-08-16 | Inflammation associee au recepteur couple a la proteine g |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1364017A2 (fr) |
JP (1) | JP2004505648A (fr) |
AU (1) | AU2002212140A1 (fr) |
WO (1) | WO2002013845A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0021484D0 (en) * | 2000-09-01 | 2000-10-18 | Boehringer Ingelheim Pharma | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
US6902902B2 (en) | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
US7189524B1 (en) | 2002-11-25 | 2007-03-13 | Amgen, Inc. | Receptor ligands and methods of modulating receptors |
US7465548B2 (en) | 2003-02-17 | 2008-12-16 | Bayer Healthcare Ag | Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a |
EP1603585A2 (fr) * | 2003-03-14 | 2005-12-14 | Bristol-Myers Squibb Company | Polynucleotide codant un nouveau variant de recepteur de hm74, hgprbmy74 couple a une proteine g humaine |
WO2006021892A2 (fr) * | 2004-08-27 | 2006-03-02 | Endocube S.A.S. | Hm74 et hm74a associes a l'inflammation dans les cellules endotheliales cuboides |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998056820A1 (fr) * | 1997-06-12 | 1998-12-17 | Smithkline Beecham Corporation | Recepteur hm74a |
WO2002018938A1 (fr) * | 2000-09-01 | 2002-03-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Procede d'identification de substances influençant de maniere positive des etats inflammatoires de maladies inflammatoires chroniques des voies aeriennes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
-
2001
- 2001-08-16 AU AU2002212140A patent/AU2002212140A1/en not_active Abandoned
- 2001-08-16 JP JP2002518985A patent/JP2004505648A/ja active Pending
- 2001-08-16 EP EP01980246A patent/EP1364017A2/fr not_active Withdrawn
- 2001-08-16 WO PCT/EP2001/009466 patent/WO2002013845A2/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998056820A1 (fr) * | 1997-06-12 | 1998-12-17 | Smithkline Beecham Corporation | Recepteur hm74a |
WO2002018938A1 (fr) * | 2000-09-01 | 2002-03-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Procede d'identification de substances influençant de maniere positive des etats inflammatoires de maladies inflammatoires chroniques des voies aeriennes |
Non-Patent Citations (4)
Title |
---|
EL OUAKFAOUI SOUAD ET AL: "Granulocyte-macrophage colony-stimulating factor modulates tapasin expression in human neutrophils.", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 65, no. 2, February 1999 (1999-02-01), pages 205 - 210, XP002230379, ISSN: 0741-5400 * |
NOMURA H ET AL: "MOLECULAR CLONING OF CDNAS ENCODING A LD78 RECEPTOR AND PUTATIVE LEUKOCYTE CHEMOTACTIC PEPTIDE RECEPTORS", INTERNATIONAL IMMUNOLOGY, OXFORD UNIVERSITY PRESS, GB, vol. 5, no. 10, October 1993 (1993-10-01), pages 1239 - 1249, XP002911511, ISSN: 0953-8178 * |
PALS CORNELIEKE E G M ET AL: "Identification of cytokine-regulated genes in human leukocytes in vivo.", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 105, no. 4, April 2000 (2000-04-01), pages 760 - 768, XP008013156, ISSN: 0091-6749 * |
YOUSEFI SHIDA ET AL: "cDNA representational difference analysis of human neutrophils stimulated by GM-CSF", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 277, no. 2, 22 October 2000 (2000-10-22), pages 401 - 409, XP002179732, ISSN: 0006-291X * |
Also Published As
Publication number | Publication date |
---|---|
JP2004505648A (ja) | 2004-02-26 |
EP1364017A2 (fr) | 2003-11-26 |
AU2002212140A1 (en) | 2002-02-25 |
WO2002013845A2 (fr) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001066597A3 (fr) | Gene relatif a l'inflammation | |
WO2000025725A3 (fr) | Antagonistes fonctionnels de l'activite hedgehog | |
WO1998055508A3 (fr) | Proteines humaines ayant des domaines transmembranaires et adn codant ces proteines | |
WO2002022776A3 (fr) | Variants du facteur vii de coagulation humaine | |
CA2529179A1 (fr) | Vecteur viral aav recombine pour traitement de la maladie d'alzheimer | |
EP1719780A3 (fr) | Polypeptide 10 du type cytokine de mammifère | |
EP2011510A3 (fr) | Compositions pharmaceutiques comportant des fragments de protéine du virus de l'herpès simplex d'acitvité immunologique | |
HK1032426A1 (en) | Amino-terminally truncated rantes as chemokine antagonists | |
WO1999006440A8 (fr) | Nouveaux peptides synthetiques possedant des proprietes antimicrobiennes et de neutralisation d'endotoxines et permettant de lutter contre le syndrome de septicemie | |
WO2003048205A3 (fr) | Proteines a activite inhibitrice de l'il-6 | |
WO1999003881A3 (fr) | Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique | |
CA2287534A1 (fr) | Microparticules biodegradables pour administration soutenue de medicaments therapeutiques | |
AU2002330289A1 (en) | Preparation of a therapeutic composition | |
IT1299583B1 (it) | Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica | |
WO2002013845A3 (fr) | Inflammation associee au recepteur couple a la proteine g | |
JP2003533188A5 (fr) | ||
WO2001049711A3 (fr) | Acides nucleiques codant pour des (poly)peptides ayant une activite de chips | |
JP2006505290A5 (fr) | ||
WO2001098355A3 (fr) | Compositions cgi-69 et procedes d'utilisation | |
WO2002038607A3 (fr) | Recepteur | |
CA2210871A1 (fr) | Variantes de la dnase i humaine | |
WO2000068259A3 (fr) | Composition vaccinale | |
NZ505350A (en) | DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours | |
EP1219638A3 (fr) | Récepteurs couplés aux protéines-G et ayant de l'homologie avec le P2Y purinorécepteur 1 (P2Y1) | |
DE60325227D1 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001980246 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002518985 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001980246 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001980246 Country of ref document: EP |